Skip to content
10-Q

Quarterly Report

Caribou Biosciences, Inc. CRBU

0001619856-26-000036

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 99.18M sh
Shares Diluted Q1 2026 · Mar 31, 2026 95.86M sh
Shares Diluted Q1 2026 · Mar 31, 2025 92.68M sh
Capex Q1 2026 · Mar 31, 2026 $72K
Capex Q1 2026 · Mar 31, 2025 $1.04M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$26.98M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$36.73M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $12.06M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $12.36M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $29.42M
Stockholders Equity Q1 2026 · Mar 31, 2026 $102.02M
Stockholders Equity Q1 2026 · Dec 31, 2025 $122.18M
Stockholders Equity Q1 2026 · Mar 31, 2025 $217.22M
Stockholders Equity Q1 2026 · Dec 31, 2024 $252.95M
Current Liabilities Q1 2026 · Mar 31, 2026 $19.67M
Current Liabilities Q1 2026 · Dec 31, 2025 $25.41M
Total Liabilities Q1 2026 · Mar 31, 2026 $46.98M
Total Liabilities Q1 2026 · Dec 31, 2025 $53.19M
Current Assets Q1 2026 · Mar 31, 2026 $122.38M
Current Assets Q1 2026 · Dec 31, 2025 $145.23M
Total Assets Q1 2026 · Mar 31, 2026 $149M
Total Assets Q1 2026 · Dec 31, 2025 $175.37M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.26
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.43
Eps Basic Q1 2026 · Mar 31, 2026 −$0.26
Eps Basic Q1 2026 · Mar 31, 2025 −$0.43
Sga Expense Q1 2026 · Mar 31, 2026 $8.07M
Sga Expense Q1 2026 · Mar 31, 2025 $9.74M
Rd Expense Q1 2026 · Mar 31, 2026 $20.61M
Rd Expense Q1 2026 · Mar 31, 2025 $35.53M
Net Income Q1 2026 · Mar 31, 2026 −$25.09M
Net Income Q1 2026 · Mar 31, 2025 −$39.99M
Operating Income Q1 2026 · Mar 31, 2026 −$26.28M
Operating Income Q1 2026 · Mar 31, 2025 −$42.91M
Revenue Q1 2026 · Mar 31, 2026 $2.4M
Revenue Q1 2026 · Mar 31, 2025 $2.35M